CVS Health Financial Statements
9,478 Followers
CVS Health Financial Overview
CVS Health's market cap is currently ―. The company's EPS TTM is $6.157; its P/E ratio is 16.35; and it has a dividend yield of 2.18%. CVS Health is scheduled to report earnings on November 2, 2022, and the estimated EPS forecast is $2.00. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 80.64B | $ 76.83B | $ 76.60B | $ 73.79B | $ 72.62B |
| Gross Profit | $ 13.74B | $ 13.37B | $ 13.65B | $ 12.70B | $ 13.20B |
| EBIT | $ 4.61B | $ 3.53B | $ 2.18B | $ 2.75B | $ 4.37B |
| EBITDA | $ 5.70B | $ 4.59B | $ 3.29B | $ 3.88B | $ 5.51B |
| Net Income Common Stockholders | $ 2.95B | $ 2.31B | $ 1.31B | $ 1.60B | $ 2.78B |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | $ 14.99B | $ 11.34B | $ 12.53B | $ 12.84B | $ 10.13B |
| Total Assets | $ 230.28B | $ 232.87B | $ 233.00B | $ 234.89B | $ 231.16B |
| Total Debt | $ 70.15B | $ 73.22B | $ 76.02B | $ 81.35B | $ 83.65B |
| Net Debt | $ 55.16B | $ 61.88B | $ 63.50B | $ 68.51B | $ 73.53B |
| Total Liabilities | $ 154.77B | $ 158.73B | $ 157.62B | $ 160.27B | $ 157.60B |
| Stockholders Equity | $ 75.18B | $ 73.83B | $ 75.08B | $ 74.31B | $ 73.24B |
| Cash Flow | |||||
| Free Cash Flow | $ 5.04B | $ 2.51B | $ 3.41B | $ 4.91B | $ 5.36B |
| Operating Cash Flow | $ 5.44B | $ 3.56B | $ 4.00B | $ 5.52B | $ 5.85B |
| Investing Cash Flow | $ -2.13B | $ -1.99B | $ -1.44B | $ -847.00M | $ -1.11B |
| Financing Cash Flow | $ -2.46B | $ -2.65B | $ -2.83B | $ -1.97B | $ -3.37B |